Back to Search Start Over

Spinal microglia-derived TNF promotes the astrocytic JNK/CXCL1 pathway activation in a mouse model of burn pain.

Authors :
Zhang, Run
Xu, Biao
Zhang, Nan
Niu, Jiandong
Zhang, Mengna
Zhang, Qinqin
Chen, Dan
Shi, Yonghang
Chen, Danni
Liu, Kedi
Zhang, Xiaodi
Li, Ning
Fang, Quan
Source :
Brain, Behavior & Immunity. May2022, Vol. 102, p23-39. 17p.
Publication Year :
2022

Abstract

• Spinal glia attribute to the development and maintenance of burn-induced pain. • Microglia p38-TNF signaling is crucial in the early-phase of burn-induced pain. • Astrocyte JNK-CXCL1 signaling attributes to the late-phase of burn-induced pain. • Spinal microglia-derived TNF is a critical mediator in burn-induced astrogliosis. Burn injury-induced pain (BIP) is an extremely complicated condition usually resistant to analgesic drugs, while its pathogenesis remains unknown. Considerable attention has been attracted to elucidate the glial mechanisms in chronic pain. In this study, we initiatively used a mouse model of second‐degree BIP to investigate the underlying non-neuronal mechanisms at the spinal cord level. Our behavioral results showed that hind-paw burn injury caused persistent allodynia and hyperalgesia for 2 weeks in mice. Further studies revealed that both microglia and astrocytes activated in a spatially- and temporally-dependent manner in spinal cord after burn injury. In addition, the phosphorylated p38 mitogen-activated protein kinase (MAPK)-mediated tumor necrosis factor (TNF) release in spinal microglia is essentially attributed to the early stage of BIP, while the c-Jun N-terminal kinase (JNK) MAPK-dependent chemokine CXCL1 expression is mainly involved in the maintenance of pain hypersensitivity. Most strikingly, burn injury-induced pain symptoms and the activation of astrocytes were significantly suppressed by TNF inhibitor Thalidomide. On the contrary, intrathecal injection of TNF caused apparent pain hypersensitivity, accompanied by the activation of astrocytes and the upregulation of CXCL1 via the JNK MAPK signaling pathway, indicating that TNF is the key cytokine in the interaction between microglia and astrocytes at the spinal level. Moreover, treatment with the CXCR2 receptor antagonist SB225002 to block the biological activities of CXCL1 significantly attenuated the mechanical allodynia and thermal hyperalgesia in this BIP model. Taken together, this study indicates that intervention of glial pathways provides a new perspective in the management of BIP. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08891591
Volume :
102
Database :
Academic Search Index
Journal :
Brain, Behavior & Immunity
Publication Type :
Academic Journal
Accession number :
156127829
Full Text :
https://doi.org/10.1016/j.bbi.2022.02.006